Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer

This study has been completed.
Sponsor:
Collaborator:
Quintiles
Information provided by:
Taiho Oncology, Inc.
ClinicalTrials.gov Identifier:
NCT00652054
First received: March 31, 2008
Last updated: March 17, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)